摘要
目的:探讨黄芪甲苷(Astragaloside IV,As IV)对异丙肾上腺素(ISO)诱导大鼠心肌肥厚及过氧化物酶体增殖活化受体γ辅助活化因子1α(PGC-1α)的影响。方法:60只雄性大鼠分别于ISO造模前一天给予等体积黄芪甲苷(20、40、80 mg/kg/d)、普萘洛尔(40 mg/kg/d)或羧甲基纤维素钠(0.05%)灌胃,第2天同时皮下注射ISO(5 mg/kg/d),持续造模2周。通过全心质量指数(HMI)、左心质量指数(LVMI)观察心肌肥厚程度;苏木精-伊红(HE)染色法观察心脏组织形态学改变;:酶联免疫吸附测定(Elisa)检测三磷酸腺苷(ATP)、二磷酸腺苷(ADP)、单磷酸腺苷(AMP)及游离脂肪酸(FFA)的表达水平;逆转录-聚合酶链反应(RT-PCR)检测心肌组织心房钠尿肽(ANP)mRNA表达水平;蛋白免疫印迹(Western blot)检测心肌组织PGC-1α的蛋白表达水平。结果:ISO组大鼠心肌明显肥厚,HMI、LVMI及ANP mRNA的表达水平明显增加。与ISO组相比,黄芪甲苷40、80 mg/kg/d剂量组ATP/AMP、ATP/ADP比值,PGC-1α蛋白表达水平均增加;FFA含量减少。结论:黄芪甲苷可能通过过氧化物酶体增殖活化受体γ辅助活化因子1α改善异丙肾上腺素诱导的心肌肥厚能量代谢水平表达,发挥心肌保护作用。
Objective: To explore the effect of of Astragaloside IV on myocardial hypertrophy and PGC-1α in rats induced by isoproterenol( ISO).Methods: Male Sprague-Dauley( SD) rats were treated with astragalosides and propranolol by intragastric( ig) administration respectively,at a dose of 20,40,80 mg /kg /day and 40 mg /kg /day one day prior to isoproterenol or vehicle( 5 mg /kg /day,sc) for 2 week. At the end of the treatment period,HMI,LVMI and pathological section by HE staining were observed. ATP,ADP,AMP and FFA levels were detected by Elisa; The expression of ANP mRNA were determined by RT-PCR; The expression of PGC-1α were assessed by Western blot. Results: ISO model group markedly elevated the left ventricle weight( LVW) / body weight( BW),heart weight( HW) /body weight( BW) ratio and ANP mRNA level. Compared with ISO group,treatment with ASIV( 40,80 mg /kg /d) significantly improved ATP /AMP,ATP /ADP ratio and PGC-1α protein expression and reduced the accumulation of free fatty acid. Conclusions: ASIV may alleviate metabolism by regulating PGC-1α axis and protect ISO-induced cardiac hypertrophy.
出处
《中药药理与临床》
CAS
CSCD
北大核心
2014年第3期65-69,共5页
Pharmacology and Clinics of Chinese Materia Medica
基金
国家自然科学基金(81374008)